Evaluation of Ecography as a Diagnostic Tool in the Carpal Tunnel Syndrome Compared to the Studies of Electroconduction

September 23, 2022 updated by: Hospital Universitario Virgen Macarena
The main objective is to investigate the value of ultrasound in the diagnosis of Carpal Tunnel Syndrome (CTS), and among the secondary objectives, to establish the ultrasound parameters that are predictors of CTS in comparison with neurophysiological studies, attempting to standardize a protocol and reference values that determine the presence or absence of CTS. Finally, cost-effectiveness analysis is proposed.

Study Overview

Detailed Description

The reference test with which the ultrasound is compared is the neurophysiological test (NPT).

The expected timeline for the study is to be performed between July 2020 and May 2023.

Study Type

Observational

Enrollment (Anticipated)

438

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Sevilla, Spain, 41009
        • Recruiting
        • Hospital Universitario Virgen de la Macarena
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Aguas Santas Jiménez Sarmiento
        • Sub-Investigator:
          • Mercedes Álvarez López
        • Sub-Investigator:
          • Gema Jiménez Jurado

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with clinical suspicion of CTS that come consecutively from the Neurophysiology Department of the Virgen Macarena Hospital in Seville (Spain).

Description

Inclusion Criteria:

  1. Presenting clinical symptoms suggestive of CTS, at least one of the following:

    • Neuropathic profile pain in wrist-hand at the level of the median nerve territory (wrist, first-second-third, and radial half of the fourth finger by palmar and/or volar side), possibility of irradiation of the pain towards the forearm and/or arm.
    • Nocturnal symptoms.
    • Hypotrophy or atrophy of the thenar eminence.
    • Self-described sensory alteration (sensation of cramping, numbness, tingling, hypoalgesia or analgesia).
  2. Age: 18 to 75 years.
  3. Consent to participate in the study.

Exclusion Criteria:

  1. Previous surgery on the wrist
  2. Acquired or hereditary pathology causing peripheral neuropathies
  3. Polyneuropathy of any etiology
  4. Rheumatoid arthritis
  5. Diabetes Mellitus

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Intervention
An electroneurography and an ultrasound study will be performed to patients with clinical suspicion of CTS and fulfilling the inclusion/exclusion criteria.
based on the recommendations of the American Association of Electrodiagnostic Medicine (AAEM) (1)
ultrasound protocol described by Chen et al. (2)
Other Names:
  • Nerve conduction study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Demographic variables
Time Frame: January 2021 to September 2022
Sex, age, time of evolution of the clinic, manual dominance, hand affected, body mass index, employment status, type of work (pink, white or blue collar), time worked, triggers of symptoms, what symptoms are relieved with, as well as toxic habits, whether they are smokers (to be answered affirmative or negative) or alcohol consumers (to be answered affirmative or negative).
January 2021 to September 2022
Electrodiagnostic variables
Time Frame: January 2021 to September 2022
Motor conduction velocity of the median nerve (calculating distal motor latency and wrist-elbow motor conduction velocity), motor conduction velocity of the ulnar nerve (calculating distal motor latency, lower and upper wrist-elbow motor conduction velocity), orthodromic sensory conduction of the median, ulnar and radial nerve, as well as antidromic sensory conduction of the median, ulnar and radial nerve.
January 2021 to September 2022
Ultrasound variables
Time Frame: January 2021 to September 2022
The cross-sectional area (CSA), range of median nerve thinning, wrist-forearm index, flexor retinaculum bulge, power Doppler uptake, and existence of notches
January 2021 to September 2022
Boston Carpal Tunnel Questionnaire
Time Frame: January 2021 to September 2022
January 2021 to September 2022
Cost evaluation
Time Frame: From September 2022 to May 2023
Costs of the consumables established by the Andalusian Health Service used in both tests and the average time for each of the tests
From September 2022 to May 2023

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 1, 2020

Primary Completion (ANTICIPATED)

October 30, 2022

Study Completion (ANTICIPATED)

May 31, 2023

Study Registration Dates

First Submitted

September 23, 2022

First Submitted That Met QC Criteria

September 23, 2022

First Posted (ACTUAL)

September 27, 2022

Study Record Updates

Last Update Posted (ACTUAL)

September 27, 2022

Last Update Submitted That Met QC Criteria

September 23, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The full study protocol can be accessed by contacting the trial team at (e-mail). Anonymized participants level data and statistical codes used for the analysis are available on request and subject to data sharing agreements. Data sharing may only be possible after relevant embedded trials have been published.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe